Chief Financial Officer · Evelo Biosciences, Inc. (EVLO)

Marella Thorell

FY2022 is the first fiscal year CompBrief holds for Marella Thorell as a named executive officer of Evelo Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,029,097

Salary $132,462Stock awards $0Bonus $100,000

3rd of 3 named executive officers at Evelo Biosciences by FY2022 total.

3 named officers on file for Evelo Biosciences, FY2022

Marella Thorell’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Evelo Biosciences’s whole pay program stands against its peers

  • Evelo Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EVLO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Marella Thorell’s full pay file as a PDF — free

More than this page: up to 10 years of Marella’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Marella Thorell compensation by year

Evelo Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Evelo Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$132,462
Bonus$100,000
Stock awards$0
Option awards$763,576
Non-equity incentive$0
Pension and deferred compensation$0
All other$33,059
Total$1,029,097

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evelo Biosciences, Inc. DEF 14A filed April 28, 2023, accession 0001193125-23-127000, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Evelo Biosciences, Inc. filed document, accession 0001193125-23-127000. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option440,000—$2.29

Per the Outstanding Equity Awards at Fiscal Year-End table in Evelo Biosciences, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Evelo Biosciences’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Balkrishan GillChief Executive Officer$1,721,635
Jonathan ZungFormer Chief Development Officer$1,107,563
Marella Thorell · this pageChief Financial Officer$1,029,097

The full Evelo Biosciences compensation record

free company brief

This page is one person within Evelo Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evelo Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Marella Thorell's compensation dossier · One-time report. No refunds.